Biotechnology | featured news

Federal Circuit Reaffirms Patentability of Human Genes

In a closely watched case with huge repercussions for the biotechnology industry, a federal appeals court has held for the second time that isolated human genes are patent-eligible.

 

Johnson & Johnson buys 18 percent stake in Crucell

Health care giant Johnson & Johnson is jumping into the increasingly hot vaccine business by taking an 18 percent stake in Dutch biotechnology company Crucell NV and focusing more on preventive medicine....

 

Gates Foundation Sells Off Almost All HealthCare Investments

The Bill and Melinda Gates Foundation sold off almost all of its pharmaceutical, biotechnology and health-care investments in the quarter ended June 30.

 

Subscribe to this RSS topic: Syndicate content